ADVFN US – Market Content Editor
-
Avient Tops Q4 Forecasts, Sees Continued Earnings Growth in 2026
Avient Corporation (NYSE:AVNT) reported fourth-quarter results that slightly exceeded Wall Street expectations, with shares inching up about 0.3% in after-hours trading. The specialty materials company posted adjusted earnings per share of $0.56 for the quarter, ahead of the $0.55 consensus estimate. Revenue came in at $761 million, beating forecasts of $750.17 million and marking a…
-
TransUnion Slips as 2026 Outlook Trails Expectations Despite Q4 Beat
TransUnion (NYSE:TRU) declined about 2.5% in premarket trading Thursday after issuing 2026 guidance that fell short of analyst forecasts, overshadowing stronger-than-expected fourth-quarter results. The credit reporting agency posted adjusted earnings of $1.07 per share for the fourth quarter, topping the $1.03 consensus estimate. Revenue rose 13% year over year to $1.17 billion, ahead of the…
-
Restaurant Brands Tops Q4 Estimates on International Burger King Strength
Restaurant Brands International (NYSE:QSR) reported fourth-quarter results that outpaced market expectations, fueled by solid international momentum at Burger King. System-wide comparable sales rose 3.1% in the quarter, improving from 2.5% a year earlier and beating Bloomberg consensus forecasts for 2.55% growth. On an adjusted basis, earnings per share reached $0.96 for the quarter ended December…
-
Genesis Energy Misses Q4 EPS Estimates Despite Strong Offshore Performance
Genesis Energy LP (NYSE:GEL) reported fourth-quarter 2025 earnings that came in below Wall Street expectations, though revenue rose year over year and offshore operations delivered solid momentum. Adjusted earnings per unit were $0.04, well under the $0.28 consensus forecast. Revenue totaled $440.75 million, up from $398.92 million in the same quarter of 2024. Shares edged…
-
Fortis Tops Q4 Profit Forecasts on Regulated Asset Expansion
Fortis Inc. (NYSE:FTS) delivered fourth-quarter adjusted earnings that comfortably exceeded analyst expectations, supported by continued growth in its regulated utility operations. Adjusted earnings per share for the quarter came in at $0.90, well above the $0.61 consensus estimate. Net earnings for the fourth quarter totaled $422 million, or $0.83 per share, up from $396 million,…
-
Paycom Under Pressure as 2026 Revenue Outlook Misses Expectations
Paycom Software Inc (NYSE:PAYC) is facing potential near-term pressure after issuing 2026 revenue guidance that came in below Wall Street forecasts, overshadowing an otherwise steady fourth-quarter performance. The payroll and HR software provider projected total revenue of $2.185 billion for 2026, implying 6.5% year-over-year growth. That fell short of analyst expectations of $2.225 billion, or…
-
West Pharma Gains More Than 5% After Q4 Earnings Outperform
West Pharmaceutical Services Inc (NYSE:WST) advanced over 5% in premarket trading Thursday after reporting fourth-quarter results that topped analyst projections, supported by robust demand for its higher-margin product lines. The injectable drug packaging and delivery specialist posted adjusted earnings of $2.04 per share for the quarter, comfortably above the $1.84 consensus estimate. Revenue reached $805…
-
Lincoln Financial Climbs Nearly 4% After Q4 Profit Tops Expectations
Lincoln National Corporation (NYSE:LNC) advanced about 3.8% in after-hours trading on Thursday after posting fourth-quarter results that surpassed Wall Street forecasts, closing out the year with solid momentum across its core divisions. The insurer and retirement services provider reported adjusted operating income of $434 million, or $2.21 per diluted share, ahead of analyst estimates of…
-
Check Point Ticks Higher After Q4 Profit Beat
Check Point Software Technologies (NASDAQ:CHKP) edged about 1% higher in U.S. premarket trading after posting fourth-quarter results that exceeded profit expectations, even as revenue came in slightly below consensus. The cybersecurity group reported earnings per share of $3.40 for the quarter, comfortably ahead of analyst forecasts of $2.76. Revenue reached $744.9 million, marking a 6%…
-
Novocure Soars After FDA Clears Pancreatic Cancer Device
Novocure (NASDAQ:NVCR) surged as much as 34% in premarket trading on Thursday after securing U.S. regulatory approval for its wearable therapy designed to treat pancreatic cancer. The U.S. Food and Drug Administration cleared Optune Pax for use in patients with locally advanced pancreatic cancer in combination with chemotherapy agents gemcitabine and nab-paclitaxel. The decision arrived…